1. Home
  2. PRTC vs XPER Comparison

PRTC vs XPER Comparison

Compare PRTC & XPER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRTC
  • XPER
  • Stock Information
  • Founded
  • PRTC 2015
  • XPER 1990
  • Country
  • PRTC United States
  • XPER United States
  • Employees
  • PRTC N/A
  • XPER N/A
  • Industry
  • PRTC Biotechnology: Pharmaceutical Preparations
  • XPER Semiconductors
  • Sector
  • PRTC Health Care
  • XPER Technology
  • Exchange
  • PRTC Nasdaq
  • XPER Nasdaq
  • Market Cap
  • PRTC 414.3M
  • XPER 354.5M
  • IPO Year
  • PRTC N/A
  • XPER 2003
  • Fundamental
  • Price
  • PRTC $18.50
  • XPER $7.79
  • Analyst Decision
  • PRTC Buy
  • XPER Strong Buy
  • Analyst Count
  • PRTC 1
  • XPER 3
  • Target Price
  • PRTC $45.00
  • XPER $19.00
  • AVG Volume (30 Days)
  • PRTC 3.2K
  • XPER 350.2K
  • Earning Date
  • PRTC 04-30-2025
  • XPER 05-07-2025
  • Dividend Yield
  • PRTC N/A
  • XPER N/A
  • EPS Growth
  • PRTC N/A
  • XPER N/A
  • EPS
  • PRTC 0.21
  • XPER N/A
  • Revenue
  • PRTC $4,828,000.00
  • XPER $488,877,000.00
  • Revenue This Year
  • PRTC $35.98
  • XPER $0.50
  • Revenue Next Year
  • PRTC $115.38
  • XPER $8.71
  • P/E Ratio
  • PRTC $8.24
  • XPER N/A
  • Revenue Growth
  • PRTC 44.98
  • XPER N/A
  • 52 Week Low
  • PRTC $13.30
  • XPER $6.29
  • 52 Week High
  • PRTC $32.98
  • XPER $11.08
  • Technical
  • Relative Strength Index (RSI)
  • PRTC 58.17
  • XPER 52.11
  • Support Level
  • PRTC $17.80
  • XPER $7.60
  • Resistance Level
  • PRTC $19.17
  • XPER $7.97
  • Average True Range (ATR)
  • PRTC 0.48
  • XPER 0.21
  • MACD
  • PRTC 0.13
  • XPER -0.04
  • Stochastic Oscillator
  • PRTC 74.72
  • XPER 20.38

About PRTC PureTech Health plc

PureTech Health PLC is a biopharma company developing medicines to modulate the adaptive human system. It is a cross-disciplinary healthcare company developing products that could improve the lives of patients. The company is focused on developing and commercializing highly differentiated medicines for devastating diseases, including inflammatory, fibrotic, and immunological conditions, intractable cancers, lymphatic & gastrointestinal diseases, and neurological & neuropsychological disorders, among others. It operates in the following segments: Wholly-Owned Programs, Controlled Founded Entities, and Parent Companies & Others. The company has a robust pipeline of advanced programs that are post-human proof of concept and focused on some of society's healthcare needs.

About XPER Xperi Inc.

Xperi Inc is a consumer and entertainment technology company. Its offering comprises a portfolio of software and services. The company creates extraordinary experiences at home and on the go for millions of consumers around the world, enabling audiences to connect with content in a more intelligent, immersive, and personal way. Its business is divided into four categories based on the products delivered and customers served: Pay-TV, Consumer Electronics, Connected Car, and Platform Solutions. It generates the majority of its revenue from the Consumer Electronics segment. Its also have sales in Japan, Europe and Middle East, China, South Korea, Latin America, and Others.

Share on Social Networks: